Ergebnis der Suchanfrage nach Innere
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- 6Ein Dokumentmehr
Leipzig Tourismus und Marketing GmbH
6Leipzig’s Festival of Lights Commemorates 35 Years of Peaceful Revolution
2 DokumentemehrKoehler Group supports people with disabilities through the Leben mit Behinderung Ortenau e.V. association
mehrAcousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August ...
mehr- 9
PR | Aid by Trade Foundation Publishes Annual Report 2023: EUR 8.1 Million in Revenue to Increase Sustainability in Fibre and Textile Production
Ein Dokumentmehr - 8
The Good Cashmere Standard Boosts Level of Animal Welfare and Transparency
Ein Dokumentmehr Imperial Riding School - Autograph Collection Hotels
Imperial Riding School, Autograph Collection opens in May 2024
Vienna, Austria (ots) - Imperial Riding School, Autograph Collection is expected to open in May in Vienna's third district, marking the brand debut of Autograph Collection Hotels in Austria. Transforming from the former imperial military riding school, the hotel has been redesigned to combine its historic elegance with the inspiring zeitgeist. The hotel will offer 342 guestrooms decorated with a new design concept ...
mehrHearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study. The PROHEAR-Study is a placebo-controlled, Phase 2a study with split-body design, which investigates the otoprotective efficacy ...
mehrLeipzig Tourismus und Marketing GmbH
7Leipzig Event Highlights 2024
Ein DokumentmehrAcousia Therapeutics attracts new investor on its path to make hearing loss a treatable disease
Tübingen (ots) - - German pioneer biotech accelerates hearing loss solution development with fresh capital boost Acousia Therapeutics GmbH, a clinical-stage biotech company developing drug candidates against acute and chronic forms of hearing loss, proudly announces Esperante Ventures as the latest addition to its esteemed group of investors. The infusion of fresh ...
mehrWINNIE HARLOW USES COCA-COLA AI TO BRING A FRESH PERSPECTIVE TO KINDNESS AND EMPOWERMENT DURING THE HOLIDAYS
New York (ots/PRNewswire) - Supermodel and beauty entrepreneur, Winnie Harlow, is sharing her Coca-Cola AI generated holiday cards to give fans a unique take on what's most important to her this festive season: kindness and empowerment. Winnie, a leading advocate for representation who has redefined beauty ...
mehrEnergy at its best: German battery pioneer CustomCells unveils new brand identity
mehrPM: Spatenstich in Berlin-Marienfelde: DHL Freight plant nachhaltiges Terminal an der Buckower Chaussee / PR: Ground-breaking ceremony in Berlin: DHL Freight plans sustainable terminal near the inner city
2 DokumentemehrLeipzig Tourismus und Marketing GmbH
7Leipzig – Home of the Peaceful Revolution of 1989
Ein DokumentmehrHearing Loss Company Acousia Therapeutics Green Lighted for Game-Changing Phase 2 Trial
Tübingen, Germany (ots/PRNewswire) - Acousia Therapeutics, a pioneer clinical-stage biotech company focused on the development of novel drug therapies for the prevention and treatment of acute and chronic forms of hearing loss, received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic ...
mehrHearing Loss Company Acousia Therapeutics Green Lighted for Game-Changing Phase 2 Trial
Tübingen, Germany (ots) - Acousia Therapeutics, a pioneer clinical-stage biotech company focused on the development of novel drug therapies for the prevention and treatment of acute and chronic forms of hearing loss, received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic otoprotectant ...
mehrHearing loss company Acousia Therapeutics to present key learnings and data from lead development programs at US and European meetings in August and September
Tübingen, Germany (ots) - Acousia Therapeutics GmbH to share key learnings and data from its lead candidate development programs — clinical stage ACOU085 and late preclinical stage ACOU082 — during four presentations at industry and research meetings from August 29 to September 5. From August 29–31, Acousia ...
mehrLAMILUX Composites: Lightweights for dry freight trailers
Ein DokumentmehrZentralrat Deutscher Sinti und Roma
“It is our duty and responsibility to remember“ / European Holocaust Memorial Day for Sinti and Roma 2023
2 DokumentemehrLAMILUX Composites protect packages and vehicles
Ein Dokumentmehr- 9
Munich: 950 m² LAMILUX Glass Roof PR60 in NEWTON office building of TÜV Süd Group
mehr LAMILUX Composites at Caravan Salon 2023, Hall 13 Stand A85
Ein Dokumentmehr- 2
Hellmann expands product portfolio in Switzerland and opens Direct Load location in Kloten
mehr Leipzig Tourismus und Marketing GmbH
5Explore The Leipzig Region By Bike – Top 5 Routes
Ein DokumentmehrGood Game: Hamburg-based creative agency Hello White Parrot develops first advertising campaign for online poker platform GGPoker / Featuring Till Lindemann
mehrHellmann expands in Austria: New Direct Load location in Kufstein
mehrLeipzig Tourismus und Marketing GmbH
9Leipzig Event Highlights 2023
mehrEE Ranked First in the connect Mobile Network Test 2023 / EE is followed by Vodafone, Three and O2; all operators provide strong 5G city coverage
mehrHearing loss company Acousia Therapeutics completes clinical Phase 1 study with its small molecule
Tübingen, Germany (ots) - Hearing loss company Acousia Therapeutics GmbH announced the successful completion of its ACOU085 clinical Phase 1b study today, following the final visit of the last patient treated with the highest ACOU085 dose. ACOU085 is a proprietary small-molecule drug candidate under clinical ...
mehrTechnische Universität München
Quantum technology for cancer imaging
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10808 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/news-and-events/all-news/press-releases/details/quantum-technology-for-cancer-imaging NEWS RELEASE Quantum technology for cancer imaging Applied quantum mechanics in medicine Tracing the metabolism of tumor cells using magnetic resonance imaging (MRI) ...
mehr